Get 20% Free Customization In This Report

Buy this report from - $3456

Lidocaine Ointment Market by Application (Medical, Cosmetics, and Others) and Formulation (Internal Use and Topical Use) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Pharmaceuticals	LI_183363	Pages: NA	Jun 2018 \| 795 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Lidocaine ointment is an analgesic agent, which is used to relieve pain by blocking nerve signals in the body. The ointment is used to reduce pain and discomfort caused by skin irritants such as insect bites, sun burn, minor cuts, sore mouth or throat, scratches, burns, poison ivy, and others.

Increase in applications of lidocaine as an anti-itching and pain relief drug associated with insects bites, minor cuts, burns, skin scrapes, male & women urethra, and eczema has fueled its demand, thereby driving the market growth. Furthermore, the use of the lidocaine ointment in cosmetic procedures for pain relief associated with cutaneous procedures such as laser surgery, soft tissue augmentation, and other cosmetic procedure is anticipated to fuel the market growth. In addition, rise in disposable income and increase in awareness of preventive healthcare among population are anticipated to boost the market growth. However, government regulations related to the safety and efficacy of the lidocaine ointment hinder the market growth. Ongoing R&D activities related to lidocaine ointment are anticipated to present new opportunities for the market.

The market is segmented on the basis of application, formulation, and geography. Based on the application, the market is categorized into medical, cosmetics, and others. By formulation, it is classified into internal use and topical use. The geographical breakdown of each of the aforesaid segment is covered for North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

The study provides an in-depth analysis of the global lidocaine ointment market, with current trends and future estimations to elucidate the investment pockets.
Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
The report provides a quantitative analysis to help the stakeholders to capitalize on prevailing market opportunities.
Extensive analysis of different segments facilitates to understand various products of the market.
Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Lidocaine Ointment Market Key Segment:

By Application

Medical
Cosmetics
Others

By Formulation

Internal Use
Topical Use

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

List of players profiled in the report

AstraZeneca Plc.
Glenmark Pharmaceuticals
Teligent, Inc.
Septodont Healthcare India Pvt. Ltd.
Gemini Pharmaceuticals, Inc.
Proficient Rx LP
Amneal Pharmaceuticals LLC
Taro Pharmaceuticals U.S.A., Inc.
Novocol Inc.
Centura Pharmaceuticals, Inc.

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 LIDOCAINE OINTMENT MARKET, BY APPLICATION

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MEDICAL

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. COSMETICS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. OTHERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

Chapter: 5 LIDOCAINE OINTMENT MARKET, BY FORMULATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. INTERNAL USE

5.2.1. Market size and forecast

5.3. TOPICAL USE

5.3.1. Market size and forecast

Chapter: 6 LIDOCAINE OINTMENT MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Lidocaine Ointment Market by Application
6.2.5. North America Lidocaine Ointment Market by Formulation

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe Lidocaine Ointment Market by Application
6.3.5. Europe Lidocaine Ointment Market by Formulation

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. India market size and forecast
6.4.3.4. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Lidocaine Ointment Market by Application
6.4.5. Asia-Pacific Lidocaine Ointment Market by Formulation

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Latin America market size and forecast
6.5.3.2. Middle East market size and forecast
6.5.3.3. Africa market size and forecast

6.5.4. LAMEA Lidocaine Ointment Market by Application
6.5.5. LAMEA Lidocaine Ointment Market by Formulation

Chapter: 7 COMPANY PROFILES

7.1. ASTRAZENECA PLC.

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. GLENMARK PHARMACEUTICALS

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. TELIGENT, INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. SEPTODONT HEALTHCARE INDIA PVT. LTD.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. GEMINI PHARMACEUTICALS, INC.

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. PROFICIENT RX LP

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. AMNEAL PHARMACEUTICALS LLC

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. TARO PHARMACEUTICALS U.S.A., INC.

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. NOVOCOL INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. CENTURA PHARMACEUTICALS, INC

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.